The cell injury caused by oxidized lipoproteins was among the first findings that led to the theory that oxidized low-density lipoproteins (ox-LDL) are a key factor in atherogenesis. 15, 16 Of note, oxidized lipoproteins and their constituents have numerous harmful effects on cell types found in atherosclerotic lesions, including induction of apoptosis through both the cell death receptor and mitochondrial pathways. [17] [18] [19] [20] [21] The toxic lipid constituents of ox-LDL, including a variety of oxysterols, are candidates for the in vivo effectors of this cytotoxicity. 20, 21 Liver X receptors, Insigs, and members of the oxysterol-binding protein-related protein (ORP) family have been identified as key cellular oxysterol receptors. 22 However, further study is necessary to identify the critical receptors responsible for oxysterol-induced apoptosis.
The ORP family has been implicated in cellular lipid metabolism, vesicle transport, and cell signaling. [23] [24] [25] [26] Certain ORPs bind and transport oxysterols, cholesterol, and phosphoinositides. [27] [28] [29] ORP4 (also known as oxysterol-binding protein 2) has been reported to bind oxysterols; it is expressed constitutively in brain, heart, and testis 30, 31 and is present as 3 major variants, oxysterol-binding protein-related protein 4 L (ORP4L), ORP4M, and ORP4S. 30, 32 Early studies reported that ORP4L was detectable in peripheral blood leukocytes from patients with chronic myeloid leukemia, but not from healthy donors. 33, 34 Recent reports consistently indicate that ORP4L is involved in tumor cell proliferation and survival 32 and a target of the natural steroidal saponin with antiproliferative activity, OSW-1. 35 ORP4 knockout mice exhibit sperm apoptosis, indicating that ORP4 is essential for the survival of specific cell types. 31 In this study, we investigate the role of ORP4L in macrophage survival and in the development of atherosclerotic lesions in mice.
Methods

Animal Procedures
All animal experiments were approved by the Ethics Committee for Animal Experiments of Jinan University and performed in compliance with the China government guidelines. Mice were housed in sterilized filter-top cages and given unlimited access to food and water with 12/12 dark/light cycle. ORP4L −/− mice were crossed with LDL receptor (LDLr) −/− mice on the C57BL/6J background purchased from Jackson Laboratory to generate LDLr 
Analysis of ORP4L Protein Interactome
Rabbit antibody against human ORP4L was produced by immunizing New Zealand White rabbits with a recombinant protein carrying amino acid residues 382 to 485 of human ORP4L. This antibody was used for proteomics analysis only. RAW264.7 cells were washed twice with ice-cold PBS and incubated for 30 minutes on ice with lysis buffer (50 mmol/L Tris-Cl, 150 mmol/L NaCl, 0.5 mmol/L MgCl 2 , 10% glycerol, and 0.5% Triton X-100, pH 8.0) supplemented with Protease Inhibitor Cocktail (Roche Group). Cell lysates were centrifuged for 10 minutes at 12,000 g. The supernatants were immunoprecipitated with this anti-ORP4L or control antibody coupled to CNBr (cyanogen bromide)-activated sepharose (GE Healthcare). The ORP4L and its interacting proteins were eluted and subjected to 10% SDS-PAGE followed by in-gel tryptic digestion and mass spectrometric identification as described previously. 36 
Calcium Efflux Assay
Cells were plated on glass-bottomed dishes and incubated with 10 μmol/L Fluo-4 am (Invitrogen) for 60 minutes at 37°C in extracellular calcium buffer (130 mmol/L NaCl, 5 mmol/L KCl, 1.5 mmol/L CaCl 2 , 1 mmol/L MgCl 2 , 25 mmol/L Hepes, pH 7.5, 1 mg/mL BSA, and 5 mmol/L glucose) in dark, after which they were washed by extracellular calcium buffer and additionally incubated for 30 minutes at 25°C to permit dye de-esterification. Cells were excited with a lowintensity 488-nm laser peak. Images were acquired at 2-s intervals under time-lapse mode using confocal microscopy (Zeiss LSM 510 Meta laser system). Fluorescence was imaged for 2 minutes before the C5a (10 nmol/L) was added into the suspension. Image data were subsequently analyzed using ImageJ (National Institutes of Health) and presented as a ratio of F/F0 in final results, where F0 represents baseline fluorescence intensity in each cell.
Computer Docking
The homology model of ORP4L was generated using Molecular Operating Environment (http://www.chemcomp.com) software by using the structure of oxysterol-binding protein homology 3 as a template (PDB entry code: 4IC4). The structure of core sequence of these 2 models is highly conserved (Online Figure VIII) . Hydrogen atoms were added to the protein using the MOE modeling suite before carrying out the docking studies. Minimizing contacts for hydrogen, the structures were subjected to an Amber99 energy minimization protocol. The structure of 25-hydroxycholesterol (25-OHC) was minimized, the atomic partial charges were calculated with the MMFF94s force field, and all possible ionization states were generated at pH 7.0 using the MOE suite. 25-OHC was docked into the homology model using MOE software; the binding site was modeled based on previous information on the sterol binding site. 37 The default Triangle Matcher was used as the placement method followed by force field refinement, and London dG scoring was used for the docking. The top scoring conformation of compound was kept for analysis. Ligand interactions were generated by Chimeria.
38
Bone Marrow Transplantation
Recipient LDLr −/− mice were exposed to a single dose of 9 Gy (0.19 Gy/min, 200 kV, 4 mA) total body irradiation, using a γ-ray source (Jixing Group) with a 6-mm aluminum filter. Bone marrow cells were isolated from C57BL/6 mice by flushing the femurs and tibias with PBS. Single-cell suspensions were prepared by passing the cell mass through a cell strainer with 27 pond needle. 1×10 8 cells were infected with either high titer (1×10 9 TU/mL) Lenti-Mock or Lenti-ORP4L lentivirus carrying GFP (green fluorescent protein) tag prepared by Shanghai GenePharma Co. in the presence of 5 μg/mL polybrene (multiplicity of infection=100). At 48 hours post infection, GFPpositive cells were sorted by flow cytometry and injected into the tail vein of the irradiated recipients (1×10 7 cells per mouse, n=6 mice per group). Starting at 4 weeks post bone marrow transplantation, the mice were fed HFD for 17 weeks. 
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Atherosclerotic Lesion Analysis
Mice were anesthetized, and blood samples were collected via heart puncture for lipid profile analyses. Then the cardiovascular system was perfused with PBS and fixative (4% paraformaldehyde, 5% sucrose, 50 mmol/L EDTA, pH 7.4). After removal of connective tissue and fat, the aorta was dissected from the aortic root to the iliac artery under a dissection microscope, opened by a longitudinal cut along the ventral surface and immersed in the fixative for 12 hours before being rinsed with PBS and stained with oil red O (SigmaAldrich). Stained aortae were washed in 60% isopropanol and imaged with a TOUPCAM industrial digital camera. Quantification of the percentage of aortic surface area occupied by oil-red-O-positive plaque was performed using digital image analysis software (Image-Pro plus 6.0). For analysis of aortic roots, perfused aortas were fixed and embedded in optimal cutting temperature embedding medium. Subsequently, the aortic root area was sliced by frozen slicer (Leica CM1850). Every 7-μm cross section was collected starting from the end of the aortic sinus. The atherosclerotic lesion areas were stained with oil-red-O-stained and imaged with a TOUPCAM industrial digital camera, and the quantification of atherosclerotic lesion area occupied by oil-red-O-positive plaque was performed using digital image analysis software (Image-Pro plus 6.0). The mean lesion area (in μm 2 ) was quantified by averaging 6 sections per mouse that were spaced 3 sections apart, starting from the base of the aortic root.
The aorta sections were also stained with hematoxylin and eosin. Then, the stained aorta were washed in 70% ethanol and imaged with industrial digital camera TOUPCAMTM. The necrosis areas were circumscribed with black lines by using Adobe illustrator CS6.0 (Adobe) based on characteristic morphological features of necrosis (the area of hematoxylin and eosin-negative acellular and anuclear white areas). Plaque necrotic areas were quantified from the average of 6 sections per mouse that were spaced 3 sections apart and normalized to the total lesion area.
Statistics
The data are displayed as mean±SD. The n numbers for each group are indicated in the figure legends. All data presented in the study fit into a normal distribution and hence a Student 2-tailed t test was used for determining statistical significance between 2 groups, whereas a 1-way ANOVA with Bonferroni correction was applied while evaluating statistical significance between multiple groups. P<0.05 were regarded as statistically significant.
Study Approval
This study was approved by the Institutional Ethics Committee of Jinan University and was performed in accordance with the Declaration of Helsinki. The study was conducted according to an institutional review board-approved protocol, and informed consent was obtained from all subjects. Experiments involving animals were performed in accordance with the Guide for the Care and Use of Laboratory Animals (NIH publications nos. 80-23, revised 1996) and according to the institutional ethical guidelines for animal experiments.
Results
ORP4L Is Expressed in Macrophages and Protects Them From Apoptosis
Murine genomic and expressed sequence tag databases indicated that the OSBP2/ORP4 gene encodes ORP4L and 2 potential truncated variants (termed by us ORP4S-1 and ORP4S-2) from alternate transcription start sites in mouse (Online Figure IA) . These 2 variants encode 497-and 455-amino acid proteins lacking a PH domain (accession numbers NP_001289560 and NP_001289559), respectively. We first designed PCR primer sets to confirm the presence of ORP4 isoforms in mouse tissues. ORP4L mRNA was present in brain, heart and testis (Online Figure IB, left) , whereas the reverse transcription-polymerase chain reaction could hardly detect ORP4S-1 and ORP4S-2 variants in the above 3 tissues (Online Figure IB, right) . Therefore, we focused on ORP4L in further functional study of the OSBP2/ORP4 gene.
Similar to previous observations, 30 ,31 the ORP4L protein was found constitutively expressed in brain, heart, and testis, but it was virtually absent from other mouse tissues. Surprisingly, we found that the ORP4L protein and mRNA can also be detected in macrophages isolated from the peritoneal cavity of mouse ( Figure 1A ; Online Figure IB , left). The ORP4L protein was absent in monocytes, but was significantly upregulated in monocyte-derived macrophages differentiated using macrophage colony-stimulating factor ( Figure 1B ). Heart section staining by immunofluorescence indicated weak expression of ORP4L in cardiomyocytes but strong immunoreactivity in cardiac macrophages ( Figure 1C ). These results indicated that ORP4L expression is induced during monocyte to macrophage differentiation and may play an important role in macrophage physiology. To study the role of ORP4L in vivo, we generated ORP4L-knockout mice by gene targeting (Online Figure IC and ID) and confirmed the absence of ORP4L protein in macrophages and testes of the knockout animals (Online Figure IE) . We examined the cell subsets in peripheral blood and found a similar percentage and Figure 1 Continued. M-CSF (50 ng/mL) for 7 d were collected for analysis. C, Confocal microscopy analysis of ORP4L (red) and CD68 (green) in heart sections. The nuclei were stained with Hoechst33342 (blue). Scale bars, 100 μm. D, Left, Transendothelial migration of peritoneal macrophages from wild-type (WT) or ORP4L-knockout (ORP4L −/− ) mice (n=4 mice per group) in response to C5a (10 nmol/L, 4 h) or SDF-1 (stromal cell-derived factor 1; 100 ng/mL, 4 h). The indices were calculated by dividing the number of F4/80-positive cells in the presence of ligand by that in its absence; middle, phagocytic capacity of macrophages from WT or ORP4L −/− mice (n=4 mice per group) to take up uncoated or oxidized low-density lipoprotein (ox-LDL)-coated FluoSphere beads; right, uptake of apoptotic Jurkat T cells. Macrophages from WT or ORP4L −/− mice (n=4 mice per group) were incubated with CFDA SE (carboxyfluorescein diacetate succinimidyl ester)-labeled apoptotic Jurkat T cells, detached, stained with F4/80 antibody and analyzed by fluorescence-activated cell sorter (FACS). The median fluorescence intensity of CFDA SE associated with F4/80-positive cells was determined. E, Percentage of apoptotic peritoneal macrophages isolated from WT or ORP4L −/− mice after injection with thioglycolate for 3 d (n=4 mice per group). F, ORP4L re-expression abolished apoptosis in the presence of inducers. WT or ORP4L −/− mice were injected with thioglycolate for 3 d, and the peritoneal macrophages were isolated and transfected with control or ORP4L cDNA for 12 h and then cells were incubated with tumor necrosis factor (TNF)-α (10 ng/mL)/cycloheximide (CHX; 10 μg/mL), or lipopolysaccharide (LPS; 1 μg/mL)/CHX (10 μg/mL) for 24 h. Representative images from the FACS analysis can be found in Online Figure IIA . G, Decreased sensitivity of peritoneal macrophages to apoptosis induction. After transfection of ORP4L cDNA for 12 h, cells were incubated with or without 10 μmol/L 25-OHC, 100 μmol/L per mL ox-LDL, TNF-α (10 ng/mL)/CHX (10 μg/mL) or LPS (1 μg/mL)/CHX (10 μg/mL) for 24 h, followed by determination of apoptosis. The data represent mean±SD from at least 3 separate experiments each analyzed in triplicate. **P<0.01, **P<0.01, ***P<0.001. FITC indicates fluorescein isothiocyanate; NS, not significant; PI, propidium iodide; and SSC, side scatter. absolute numbers of monocytes in wild-type (WT) and knockout animals (Online Figure IF) .
Next, we investigated the role of ORP4L in regulation of macrophage responses including migration, phagocytosis, and apoptosis. The effects of ORP4L deficiency on macrophage chemotaxis in response to C5a and SDF-1 were examined: no significant effects were observed on macrophage migration through an endothelial cell monolayer ( Figure 1D , left). Likewise, ORP4L deficiency did not affect the ability of macrophages to take up uncoated or ox-LDL-coated FluoSphere beads ( Figure 1D , middle) nor did it affect the engulfment of anti-Fas antibody-induced apoptotic Jurkat T cells ( Figure 1D , right). As ORP4 deletion has been reported to increase sperm apoptosis, 31 we next examined whether ORP4L modulates macrophage apoptosis. When compared with cells from WT mice, a significant increase in macrophage apoptosis was detected in preparations from ORP4L −/− mice ( Figure 1E ). The combination of tumor necrosis factor-α or lipopolysaccharide with cycloheximide has been shown to induce macrophage apoptosis. 9, 39 Both inducers induced greater apoptosis of ORP4L-null macrophages than WT macrophages ( Figure 1F ). Importantly, the increase of apoptosis could be abolished by re-expression ORP4L cDNA in ORP4L-null macrophages ( Figure 1F ; Online Figure IIA) .
The role of ORP4L in regulation of apoptosis was further investigated in peritoneal macrophages overexpressing ORP4L. Oxysterols and ox-LDL are potent inducers of macrophage apoptosis. 16, 20, 40 The number of apoptotic cells was increased on 25-OHC or ox-LDL treatment, but the apoptosis induced by these treatments was significantly reduced in ORP4L overexpressing cells ( Figure 1G ). Similar results were observed in macrophages treated with tumor necrosis factor-α/cycloheximide and LPS/cycloheximide ( Figure 1G ). This resistance to 25-OHC and ox-LDL-induced apoptosis could also be recapitulated in the mouse macrophage-like RAW264.7 cell line (Online Figure IIB) . Given that there were no differences in macrophage migration, phagocytosis, or uptake of ox-LDL or apoptotic cells by ORP4L −/− macrophages but enhanced apoptosis, we conclude that ORP4L functions on regulation of macrophage survival via protecting them from apoptosis.
ORP4L Is Required for Ca 2+ Release in Macrophages
To identify the mechanism of ORP4L function in macrophages, we first studied the ORP4L protein interactome by coimmunoprecipitation-based proteomic analysis in RAW264.7 cells. Anti-ORP4L antibody and control IgG immunoprecipitates of cells were separated by SDS-PAGE (Figure 2A) , and polypeptides specifically associated with ORP4L were identified by mass spectrometry. A total of 12 proteins were identified as potential ORP4L binding partners by subtracting proteins precipitated by control IgG from those identified in anti-ORP4L precipitated specimens (Online Table I ). Gα q/11 and PLCβ3 were among the candidates. We further confirmed these interactions in RAW264.7 cells and peritoneal macrophages by a coimmunoprecipitation assay ( Figure 2B ). Immunofluorescence staining demonstrated the colocalization of ORP4L with Gα q/11 and PLCβ3 in suspension and adherent peritoneal macrophages ( Figure 2C ). These proteins appeared more concentrated in the cellular plasma membrane on Ca5 stimulation ( Figure 2C ), consistent with their observed interactions and a putative involvement in ligand-induced signal transduction. Yeast 2-hybrid analyses with a series of ORP4L deletions showed that the region of amino acids 445 to 513 in ORP4L (a domain absent in ORP4S-1 and ORP4S-2) is required for the binding to PLCβ3 (Online Figure IIIA and IIIB). We analyzed cellular protein expression profiles and found that, like ORP4L, Gα q/11 and PLCβ3 were absent in monocytes, but all of them were upregulated in macrophages ( Figure 2D ). These results suggested that ORP4L/Gα q/11 / PLCβ3 assemblies arise on macrophage maturation.
PLCβs can be activated by Gα q/11 -coupled receptors on ligand stimulation. 41, 42 PLCβ3 is a major functional PLC isoform that is activated by many G-protein-coupled ligands in macrophages. 10 Interaction of ORP4L with Gα q/11 and PLCβ3 in macrophages indicated that ORP4L may be involved in G-protein-coupled ligand-induced signaling in this cell type. To test this, we first used C5a, a ligand signaling through a G-protein-coupled receptor. 43 We further investigated the putative role of ORP4L in peritoneal macrophages isolated from WT or ORP4L −/− mice. Western blot analysis showed that the phosphorylated form of PLCβ3 44, 45 was increased in WT macrophages on C5a treatment, indicating that PLCβ3 was activated on C5a treatment, whereas this effect was significantly reduced in ORP4L −/− macrophages ( Figure 2E ). In contrast, ORP4L overexpression in peritoneal macrophages and RAW264.7 cells increased C5a-induced phosphorylated form of PLCβ3 protein level, but the effect was absent in cells overexpressing a truncated ORP4L (Δ445-513) that lacks the PLCβ3 binding domain ( Figure 2F ; Online Figure IVA) . Consistently, ORP4L deficiency led to a significant reduction in C5a-induced PLC activity ( Figure 2G , left), IP 3 production ( Figure 2G, right) , and Ca 2+ efflux from endoplasmic reticulum ] responses and quantification of [Ca 2+ ] peak amplitudes are shown (right; n=3 mice per group). I, PLC activity (left) and IP 3 production (right) in peritoneal macrophages induced by C5a (10 nmol/L, 3 min). Cells were transfected with full-length or truncated ORP4L for 24 h before measurement (n=3 mice per group). J, Calcium efflux induced by 10 nmol/L C5a in peritoneal macrophages on full-length or truncated ORP4L overexpression. Cells were transfected with full-length or truncated ORP4L for 24 h before measurement. The data represent mean±SD from triplicate analyses from each mouse (n=3 mice per group). *P<0.05, **P<0.01, ***P<0.001. NS indicates not significant.
by guest on November 18, 2017 http://circres.ahajournals.org/ Downloaded from ( Figure 2H ). We then used 2 independent short hairpin RNAs (shORP4L.1 and shORP4L.2) that reduced ORP4L expression with silencing efficiencies of ≈80% in RAW264.7 cells (Online Figure IVB ). ORP4L knockdown with the short hairpin RNAs reduced PLC activity and IP 3 production (Online Figure IVB) in RAW264.7 cells. To demonstrate the specificity and exclude shRNA off-target effects, we performed rescue experiments by re-expression of human ORP4L in these knockdown cells. Full-length ORP4L, but not the truncated protein, rescued the PLC activity, IP 3 production, and Ca 2+ efflux (Online Figure IVC) Figure IVD , right). In addition, the increased PLC activity and IP 3 production on ORP4L overexpression were partly abolished in RAW264.7 cells subjected to Gα q/11 silencing (Online Figure IVE) . These results indicated that ORP4L sustains G-protein-coupled ligand-induced Ca 2+ signaling in macrophages.
ORP4L Maintains Ca
2+ -Dependent Bcl-XL Expression
Our recent work evidenced that ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival via sustaining Ca 2+ -dependent bioenergetics.
46 M1 and M2 macrophages use different metabolic programs to fuel their effector function. M1 macrophages rely on aerobic glycolysis, whereas M2 macrophages mainly use oxidative metabolism for ATP generation. 47, 48 We compared the ATP levels in WT and ORP4L −/− macrophages and found that loss of ORP4L did not affect the ATP generation in macrophages (Online Figure V) , indicating that ORP4L does not play a major role in macrophage bioenergetics.
A previous study demonstrated that PLCβ3 deficiency induced macrophage apoptosis via downregulation of the antiapoptotic protein Bcl-XL. 10 The level of Bcl-XL in WT macrophages was markedly higher than in ORP4L −/− cells ( Figure 3A) . Quantitative RT-PCR analysis revealed that this difference may be attributed at least, in part, to a higher Bcl-XL mRNA level in WT than in ORP4L −/− macrophages ( Figure 3A) . Full-length ORP4L, but not the truncated ORP4L (Δ445-513), upregulated Bcl-XL mRNA and protein expression in peritoneal macrophages ( Figure 3B ) and RAW264.7 cells (Online Figure IVF, upper) . In addition, the truncated ORP4L was unable to rescue the decreased Bcl-XL expression on ORP4L knockdown (Online Figure IVF, lower) . Bcl-XL expression is upregulated on colony-stimulating factor-induced macrophage differentiation, 49 and we found that the induction of Bcl-XL in macrophages was inhibited in ORP4L-null cells ( Figure 3C ). Chemokine ligands are known to upregulate Bcl-XL expression and protect macrophages from apoptosis. [8] [9] [10] [11] It is thus reasonable to hypothesize that ORP4L may be required for the capacity of these ligands to regulate Bcl-XL expression in macrophages. Indeed, Bcl-XL expression in macrophages from WT mice, but not from ORP4L −/− animals, was significantly upregulated on stimulation with C5a or SDF-1 ( Figure 3D ). Bcl-XL is a key antiapoptotic protein expressed in macrophages 50 ; Its reduction in ORP4L-null macrophages was, therefore, considered a plausible reason for the increased apoptosis of these cells. To further confirm this, the exogenous expression of Bcl-XL in ORP4L-null peritoneal macrophages was demonstrated to attenuate apoptosis ( Figure 3E) . Thus, the present data suggest that ORP4L protects macrophages from apoptosis via sustained Bcl-XL expression.
Bcl-XL expression is regulated through the c-AMP responsive element binding protein (CREB) pathway, 51 which is activated through CREB serine 133 phosphorylation by Ca 2+ / calmodulin-dependent protein kinases. 52 Immunofluorescence and cell fractionation analyses showed reduction of CREB protein in the nuclei of ORP4L-null peritoneal macrophages ( Figure 3F ), indicating the inhibition of CREB activity. A series of inhibitors/agonists ( Figure 3G ) were used to reveal the detailed steps for ORP4L regulation of Bcl-XL expression. The results showed that Camk II and CREB phosphorylation and Bcl-XL expression were decreased in ORP4L-null peritoneal macrophages, and these effects were rescued by the IP 3 receptors agonist adenophostin A and the Ca 2+ transporter ionomycin ( Figure 3H ). In contrast, Camk II and CREB phosphorylation and Bcl-XL expression were increased in ORP4L overexpressing peritoneal macrophages, and these effects were abolished by the PLC inhibitor U73122, the IP 3 receptor inhibitor xestospongin C (XeC), the Ca 2+ chelating agent BAPTA, the Camkk inhibitor STO-609, the Camk II inhibitor KN-93, and the CREB inhibitor KG-501 ( Figure 3I ). The central role of this signaling pathway was further confirmed by experiments in which silencing of PLCβ3, IP 3 receptors (IP 3 R1, IP 3 R2, and IP 3 R3), CamK II, or CREB dampened the ORP4L mediated-Bcl-XL upregulation in peritoneal macrophages ( Figure 3J ). Together, these data suggest that ORP4L 
ORP4L Binds 25-Hydroxycholesterol and Counteracts Its Cytotoxicity
Proapoptotic effects of oxysterols have been reported in various cell types, but it has remained unclear whether ORPs are involved. ORP4 has been biochemically demonstrated to bind oxysterols, including 25-OHC. 30, 53 Ligand interaction studies were performed in silico by using a homology model of the ORP4 ligand-binding domain constructed by using related high-resolution structures as templates. 37 As shown in Figure 4A , the interactions between 25-OHC hydroxyl groups and the protein are predicted to be strong and stable. The 25-OHC hydroxyl groups prefer to establish arene-H interactions with Tyr588 of ORP4L, and the side chains of ORP4L Tyr634 and Lys681 prefer to establish hydrogen bonds with 25-OHC ( Figure 4A ). In vitro 25-OHC binding assay indicated that ORP4L with the 25-OHC binding site mutated (ORP4L Tyr588Gly, Tyr634Gly, Lys681Gly, designated ORP4Lm3) prevented 25-OHC binding (data not shown). Reoverexpression of the WT ORP4L, but not the ORP4Lm3, dampened apoptosis induced by 25-OHC in ORP4L-null macrophages ( Figure 4B ). These studies are consistent with the view that 25-OHC binds with high specificity and efficiency within the ORP4 ligand-binding domain of ORP4L.
Excessive treatment with 25-OHC disrupted the complex of ORP4L/Gα q/11 /PLCβ3 as analyzed by coimmunoprecipitation assay in peritoneal macrophages ( Figure 4C ). Treatment with 25-OHC decreased the C5a-induced PLC activity ( Figure 4D , left), IP 3 production ( Figure 4D, right) , and endoplasmic reticulum Ca 2+ efflux ( Figure 4E ) in peritoneal macrophages, and WT ORP4L overexpression partially rescued these decreases, whereas no rescue was observed in cells overexpressing ORP4Lm3 (Figure 4D and 4E) . Treatment with 25-OHC also reduced Camk II and CREB phosphorylation, Bcl-XL expression, and increased peritoneal macrophage apoptosis, which were rescued by WT ORP4L overexpression, but not by the mutant ORP4Lm3 ( Figure 4F and 4G) . Together, these data suggest that the dysfunction of ORP4L induced by excessive oxysterol leads to the reduction of Bcl-XL expression and subsequent macrophage apoptosis.
Atherosclerotic Lesions Are Reduced in ORP4L-Deficient Mice
Knowing that ORP4L-deficient macrophages are hypersensitive to apoptosis, it was reasonable to hypothesize that ORP4L deficiency may affect the formation of atherosclerotic lesions. Therefore, LDLr −/− ORP4L −/− mice were generated by crossing ORP4L −/− with LDLr −/− animals. We visualized ORP4L expression by immunohistochemistry in the aortic lesions of these mice and found significant ORP4L immunoreactivity in LDLr −/− mice ( Figure 5A ). Immunofluorescence microscopy showed colocalization of ORP4L with CD68, thus identifying the ORP4L-positive cells in lesions as macrophages ( Figure 5A ). Importantly, we also found significant ORP4L immunoreactivity in human atherosclerotic vessel wall (clinical information can be found in Online Table II ) and colocalization of the ORP4L staining with CD68 ( Figure 5B) , thus demonstrating the expression of ORP4L in macrophages of human atherosclerotic plaques as well. These observations provide clues for the relevance of our study to human atherosclerosis.
The LDLr 
ORP4L
−/− mice were >50% smaller than in LDLr −/− mice ( Figure 5C ). Similarly, knockout of ORP4L led to a significant decrease in plaque burden when compared with the control mice by en face analysis, with an ≈50% decrease in lesion area ( Figure 5D ).
To provide additional evidence for a specific role of macrophage ORP4L in atherogenesis, we performed adoptive bone marrow transplantation experiments with hematopoietic cells overexpressing ORP4L. Bone marrow cells from WT mice were transduced with lentivirus-Mock or lentivirus-ORP4L for 48 hours, followed by transplantation into LDLr −/− mice. The recipient mice were allowed to recover for 4 weeks and then fed a HFD for 17 weeks, followed by analysis of atherosclerotic lesion size in the aortic root. The results demonstrated that ORP4L overexpression in bone marrow cells resulted in a significant increase in aortic root lesion size ( Figure 5E , left). ORP4L overexpression in peritoneal macrophages of the animals after 17 weeks of HFD was confirmed by Western blotting (Figure 5E, right) . We conclude from the above in vivo observations that ORP4L deficiency suppresses atherogenesis in mice.
ORP4L Deficiency Is Associated With Decreased Bcl-XL Expression and Increased Macrophage Apoptosis in the Atheromas
To examine whether there are differences in Bcl-XL expression in the lesion macrophages of LDLr Figure 6A ). To determine whether ORP4L deficiency increased macrophage apoptosis in atherosclerotic lesions, we first stained serial sections from the proximal aorta with terminal deoxynucleotidyl transferase-mediated dUTP 
ORP4L
−/− mice when compared with controls ( Figure 6B ). As a complementary approach, we quantified the numbers of apoptotic macrophages in the lesions using a fluorescence-activated cell sorter-based assay. 54, 55 The proportion of CD45 + /F4/80 + apoptotic macrophages in the LDLr −/− ORP4L −/− mice was significantly higher than that in the controls ( Figure 6C ). In addition, Moma-2 staining was markedly reduced at the aortic root in LDLr 
−/− and LDLr −/− mice showed no significant differences in plasma total cholesterol, triglyceride, or cholinecontaining phospholipid concentrations (Table) . Collectively, these results support the notion that ORP4L deficiency is associated with a significant increase in apoptotic macrophages in atherosclerotic lesions, likely because of a reduction of Bcl-XL expression, which in turn contributes to a smaller lesion size and lower numbers of macrophages in the lesions.
Discussion
In this study, we demonstrated that ORP4L is expressed in macrophages and plays an essential role in G-proteincoupled ligand-induced Ca 2+ release via forming a complex with Gα q/11 and PLCβ3, which contributes to sustained Bcl-XL expression and macrophage survival. Oxysterols execute cytotoxicity via disturbance of a G-protein-coupled ligand-induced Ca 2+ signaling pathway at least in part by targeting ORP4L. We further validated the significance of this ORP4L-mediated mechanism in vivo: ORP4L deficiency in macrophages led to a significant reduction of atherogenesis and increased macrophage apoptosis within atherosclerotic lesions.
PLCβ3 has been identified as the predominant enzyme catalyzing IP 3 production in macrophages. 10 In particular, stimuli from the extracellular microenvironment via the G-protein-coupled receptors that control Ca 2+ efflux, sustain macrophage survival. In this current study, ORP4L is found expressed in macrophages but not in monocytes. It interacts with Gα q/11 and PLCβ3 to regulate both PLC activity and IP 3 production. These signaling events maintain Ca 2+ release from endoplasmic reticulum and subsequently Bcl-XL expression in response to ligand stimulation, indicating that ORP4L is essential for signaling responses to the microenvironment within the arterial wall.
It is well accepted that chemokines in the microenvironment and their receptors have important roles in atherogenesis [12] [13] [14] ; these roles of chemokines have been largely attributed to their regulation of macrophage recruitment. However, chemokines such as SDF-1 and MCP-1 are able to protect macrophages from apoptosis, suggesting that such chemokines may also contribute to atherogenesis by regulating macrophage survival. Because ORP4L is undetectable in monocytes, we hypothesize that this protein may not contribute to monocyte recruitment to the arterial wall. How ORP4L expression is regulated and whether it plays a role during macrophage differentiation at sites of arterial lesions need further investigation. Although ORP4L deficiency blocks chemokine-induced Ca 2+ signaling and increases macrophage apoptosis, it is conceivable to postulate that macrophages develop a protective mechanism supported by ORP4L in a specific physiological environment of the vessel wall. This mechanism may be highly relevant particularly in the atherosclerotic lesions, in which both chemokine ligands and oxysterols/ox-LDL are abundantly present.
Ox-LDL is known to exert cytotoxic effects and to induce apoptosis in various cell types including macrophages. Recently, studies documented the presence of oxysterols in mouse macrophage foam cells including 7α-hydroxycholesterol, 7-ketocholesterol, 4β-hydroxycholesterol, 22(R)-hydroxycholesterol, 24(S), 25-epoxycholesterol, 25-hydroxycholesterol, and 27-hydroxycholesterol (http://lipidmaps.org/#). Consistently, oxysterols are abundant in human atherosclerotic plaques. [56] [57] [58] [59] [60] Although there is no direct evidence in humans that oxysterols contribute to atherogenesis, they are thought to play an active role in plaque development. To understand the mechanisms underlying oxysterol cytotoxicity, observations by us and others have revealed that oxysterols/ox-LDL regulate cytosolic Ca 2+ concentration and oscillations. [61] [62] [63] In the present study, we built a molecular model to analyze in detail the binding of 25-OHC to ORP4L and to show a specific role of ORP4L in the cellular effects of 25-OHC by using a mutant protein with the binding site inactivated. Excessive stimulation by oxysterol interfered with the ORP4L/Gα q/11 /PLCβ3 complex and blocked Ca 2+ signaling, which reduced ligand-induced Bcl-XL expression and resulted in macrophage apoptosis. These results are similar to those observed on ORP4L deletion/knockdown. Macrophages from mice lacking ORP4L showed hypersensitivity to apoptosis, whereas overexpression of WT ORP4L, but not the oxysterol-binding-deficient mutant, reduced this hypersensitivity. Importantly, macrophages isolated from atherosclerotic lesions lacking ORP4L also showed hypersensitivity to apoptosis when compared with control cells. These data suggest that selective expression of ORP4L in macrophages supports chemokine ligand-induced The impact of macrophage apoptosis on the progression of atherosclerosis depends on the stage of lesions and is a remarkably complex issue. 64 In the early stages of lesion development, apoptosis of macrophages within the vascular wall seems to be counterbalanced by rapid and efficient engulfment and removal of the apoptotic cells by phagocytic cells, a process termed efferocytosis. Under these conditions apoptosis is suggested to reduce the number of macrophages within the lesion, resulting in the long run in a reduced lesion size.
Examples of such a beneficial effect of macrophage apoptosis on lesion burden are as follows: ABCG1 −/− LDLr −/− animals, 65 ABCA2 deletion in mouse macrophages, 66 and ATGL deficiency in mouse macrophages. 67 Consistently, deficiency of the proapoptotic key regulator p53 tended to reduce apoptosis, whereas it increased lesion area, lesion macrophage area, and necrotic core area. 68 On the one hand, there is evidence that increased apoptosis of macrophages in advanced lesions, in which the clearance of apoptotic cells is impaired, 69 leads to enhanced lesion progression, expansion of the necrotic core, and increased risk of plaque rupture. Under these conditions, macrophage apoptosis can be enhanced by, for example, elevated endoplasmic reticulum stress, 70 granulocyte macrophage colony-stimulating factor-induced IL-23 production, 71 or excessive accumulation of oxysterols. 72 Especially relevant for the present study, PLCβ3 deletion results in a reduction in atherosclerotic lesions with increased macrophage apoptosis and reduced Bcl-XL expression. 10 On the other hand, Thorp et al 73 showed that macrophage deficiency of the antiapoptotic protein Bcl-2 related to Bcl-XL resulted in increased lesional macrophage apoptosis and increased necrotic area, suggesting a critical role of Bcl-2 in macrophage survival in advanced lesions; However, no change of lesion size was observed in that study.
In our study, loss of ORP4L in LDLr −/− animals resulted in increased macrophage apoptosis and a marked reduction of the size of atherosclerotic lesions. We envision, based on the above literature that the proapoptotic effect of ORP4L deficiency mainly manifests at the early stages of lesion development reducing in the presence of efficient efferocytosis, the number of macrophages within the developing lesions and Albeit the present data suggest that the increased sensitivity ORP4L −/− macrophage may explain the observed lesion phenotype, the present data do not exclusively demonstrate a causal relationship between the 2 phenomena. Thus, further study of the mechanisms underlying the reduced lesion size is warranted. Furthermore, the plaques after 17 weeks' HFD feeding represent a relatively advanced stage. Changes in their size and composition thus reflect cumulative effects that may have arisen at different stages of the atherogenic process. Therefore, the data do not allow us to draw firm conclusions on the effects of ORP4L deficiency at any specific stage of lesion development.
Protection of macrophages by ORP4L from the proapoptotic effect of 25-OHC may be effective in early lesions in which oxysterol concentrations are moderate, and apoptotic cells can still be efficiently cleared, resulting in reduced macrophage numbers and slowing down of the plaque progression in the absence of ORP4L. In advanced lesions, the accumulation of oxysterols is so excessive and unphysiological that the protective function of proteins such as ORP4L most likely becomes insufficient to prevent further progression of the plaque. Our data suggest that excessive oxysterols/ox-LDL disturb the function of ORP4L, resulting in macrophage apoptosis, which may slow down lesion development at the early stages of atherogenesis but promote the progression of advanced lesions.
In summary, we show that ORP4L is required for G-protein-coupled ligand-induced signaling and Bcl-XL expression in macrophages. ORP4L is thus crucial for macrophage survival. The pathway discovered in this study also offers one mechanistic explanation for the oxidation injury theory of atherogenesis. Our findings point out a key role of ORP4L in the development of atherosclerosis and suggest that this protein represents a potential new target for treatment of this disease.
